Darwin Global Management, Ltd. C4 Therapeutics, Inc. Transaction History

Darwin Global Management, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$30.39 - $42.18 $4.26 Million - $5.91 Million	-140,034 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$31.96 - $46.5 $2.83 Million - $4.12 Million	-88,561 Reduced 38.74%	140,034 $5.18 Million
Q4 2020 Feb 16, 2021	BUY	$22.8 - $37.05 $5.21 Million - $8.47 Million	228,595 New	228,595 $7.57 Million

130

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $205M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Darwin Global Management, Ltd. with notifications on news.